| Product Code: ETC7916727 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Latvia`s non-injectable insulin import shipments in 2024 are primarily sourced from Lithuania, Netherlands, Switzerland, Poland, and Germany, reflecting a diversified supplier base. With a low Herfindahl-Hirschman Index (HHI) concentration, the market remains competitive. The compound annual growth rate (CAGR) from 2020 to 2024 was a robust 8.6%, indicating a healthy market expansion. Furthermore, the growth rate from 2023 to 2024 stood at 7.03%, showcasing sustained momentum in the importation of non-injectable insulin products into Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Non-Injectable Insulin Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Non-Injectable Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Non-Injectable Insulin Market - Industry Life Cycle |
3.4 Latvia Non-Injectable Insulin Market - Porter's Five Forces |
3.5 Latvia Non-Injectable Insulin Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Latvia Non-Injectable Insulin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Non-Injectable Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Latvia |
4.2.2 Growing awareness about non-injectable insulin as an alternative treatment option |
4.2.3 Technological advancements in non-injectable insulin delivery systems |
4.3 Market Restraints |
4.3.1 High cost associated with non-injectable insulin products |
4.3.2 Limited reimbursement coverage for non-injectable insulin in Latvia |
4.3.3 Regulatory challenges in the approval process for new non-injectable insulin products |
5 Latvia Non-Injectable Insulin Market Trends |
6 Latvia Non-Injectable Insulin Market, By Types |
6.1 Latvia Non-Injectable Insulin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Latvia Non-Injectable Insulin Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Latvia Non-Injectable Insulin Market Revenues & Volume, By Pills, 2021- 2031F |
6.1.4 Latvia Non-Injectable Insulin Market Revenues & Volume, By Sprays, 2021- 2031F |
6.1.5 Latvia Non-Injectable Insulin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Latvia Non-Injectable Insulin Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Latvia Non-Injectable Insulin Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Latvia Non-Injectable Insulin Market Revenues & Volume, By Online Stores, 2021- 2031F |
6.2.4 Latvia Non-Injectable Insulin Market Revenues & Volume, By Drug Stores, 2021- 2031F |
7 Latvia Non-Injectable Insulin Market Import-Export Trade Statistics |
7.1 Latvia Non-Injectable Insulin Market Export to Major Countries |
7.2 Latvia Non-Injectable Insulin Market Imports from Major Countries |
8 Latvia Non-Injectable Insulin Market Key Performance Indicators |
8.1 Patient adherence rate to non-injectable insulin therapy |
8.2 Number of healthcare providers trained in prescribing and administering non-injectable insulin |
8.3 Rate of adoption of non-injectable insulin products compared to traditional injectable insulin |
9 Latvia Non-Injectable Insulin Market - Opportunity Assessment |
9.1 Latvia Non-Injectable Insulin Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Latvia Non-Injectable Insulin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Non-Injectable Insulin Market - Competitive Landscape |
10.1 Latvia Non-Injectable Insulin Market Revenue Share, By Companies, 2024 |
10.2 Latvia Non-Injectable Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here